JAMA Articles Suggest Non-Inferiority Trials Are, In Fact, Sometimes Inferior
This article was originally published in The Gray Sheet
Executive Summary
Non-inferiority and equivalence trials are often poorly conducted and poorly reported, according to a series of articles in the Journal of the American Medical Association that could have particular implications for device firms
You may also be interested in...
FDA Defines Ground Rules For Evolving DES Clinical Trial Paradigm
Foreign drug-eluting stent trial strategies should be discussed with FDA at pre-IDE meetings to ensure that data outside the U.S. will be acceptable for premarket submissions, CDRH Division of Cardiovascular Devices Director Bram Zuckerman recommends
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.